立即開始
matt.sulli42

bullish on REGN

看多
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)  
matt.sulli42  
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
biotechnology biotech REGN
1
0
biotechnology biotech regn
REGN could head north of 400 post earnings, time to get in is between now @ 358.50 and a low of around 320

相關想法

matt.sulli42
Regeneron: Will wave V be enough to break resistance?
matt.sulli42
Short WLL
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。